Suchergebnisse - "2494G1JF75"

PubPharm (391)

91

Comprehensive evaluation of the efficacy and safety of LPV/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19

enthalten in: Aging | 2021

von Wu, L. | Zheng, Y. | Liu, J. | +5

92

Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra

enthalten in: International immunopharmacology | 2021

von Mortaz, E. | Bassir, A. | Dalil Roofchayee, N. | +10

93

COVID-19 and Its Implications for Thrombosis and Anticoagulation

enthalten in: Seminars in respiratory and critical care medicine | 2021

von Berkman, S. | Tapson, V.

94

Observational study of the effects of Favipiravir vs Lopinavir/Ritonavir on clinical outcomes in critically Ill patients with COVID-19

enthalten in: Journal of clinical pharmacy and therapeutics | 2021

von Kocayiğit, H. | Özmen Süner, K. | Tomak, Y. | +5

95

Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19

enthalten in: Journal of biomolecular structure & dynamics | 2021

von Muralidharan, N. | Sakthivel, R. | Velmurugan, D. | +1

96

SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2 : An in silico drug repurposing study

enthalten in: European journal of pharmacology | 2021

von Baby, K. | Maity, S. | Mehta, C. | +3

97

Neglecting Plasma Protein Binding in COVID-19 Patients Leads to a Wrong Interpretation of Lopinavir Overexposure

enthalten in: Clinical pharmacology and therapeutics | 2021

von Stanke-Labesque, F. | Concordet, D. | Djerada, Z. | +11

98

Evidence and speculations : vaccines and therapeutic options for COVID-19 pandemic

enthalten in: Human vaccines & immunotherapeutics | 2021

von Siddique, R. | Bai, Q. | Shereen, M. | +7

99

Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19 : The TOGETHER Randomized Clinical Trial

enthalten in: JAMA network open | 2021

von Reis, G. | Moreira Silva, E. | Medeiros Silva, D. | +16

ErratumIn: JAMA Netw Open. 2021 Sep 1;4(9):e2130442. - PMID 34533579

100

Pharmacological treatment of COVID-19 : Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)

enthalten in: Medicina intensiva | 2021

von Díaz, E. | Amézaga Menéndez, R. | Vidal Cortés, P. | +6